Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Shares Outstanding (Weighted Average) (2016 - 2025)

Collegium Pharmaceutical (COLL) has 8 years of Shares Outstanding (Weighted Average) data on record, last reported at $31.6 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) fell 2.13% year-over-year to $31.6 million; the TTM value through Sep 2025 reached $31.6 million, down 2.13%, while the annual FY2024 figure was $32.1 million, 4.93% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $31.6 million in Q3 2025 per COLL's latest filing, down from $31.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $33.7 million in Q4 2023 and bottomed at $31.6 million in Q3 2025.
  • Average Shares Outstanding (Weighted Average) over 3 years is $32.3 million, with a median of $32.2 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Weighted Average): fell 4.93% in 2024, then dropped 1.65% in 2025.
  • A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $33.7 million in 2023, then fell by 4.93% to $32.1 million in 2024, then fell by 1.58% to $31.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $31.6 million in Q3 2025, $31.8 million in Q2 2025, and $31.8 million in Q1 2025.